20n Bio, an AI-powered drug discovery startup focusing on designing new proteins for therapeutics, announced the appointment of LIANG Shide, PhD, as Vice President of Computational Biology, effective May 9, 2022. Dr. LIANG will oversee the computational design and R&D of proteins for therapeutics, grow the company’s research team, and guide the company to advance drug candidates from discovery to the clinic. “We are thrilled to have Dr. LIANG join 20n Bio in this critical role...